Fred E Cohen Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

Fred E Cohen is of Intellia Therapeutics, Inc.. Currently has a direct ownership of 49,453 shares of NTLA, which is worth approximately $975,213. The most recent transaction as insider was on Jun 12, 2024, when has been sold 7,737 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.5K
18.55% 3M change
18.55% 12M change
Total Value Held $975,213

Fred E Cohen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
7,737 Added 13.53%
49,453 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
4,425 Added 9.59%
41,716 Common Stock
Jun 14 2022
BUY
Grant, award, or other acquisition
-
5,197 Added 12.23%
37,291 Common Stock
Jun 23 2021
BUY
Grant, award, or other acquisition
-
2,094 Added 50.0%
2,094 Common Stock
Jan 20 2021
BUY
Exercise of conversion of derivative security
$275,600 $13.78 p/Share
20,000 Added 40.0%
30,000 Common Stock

Also insider at

VCYT
VERACYTE, INC. Healthcare
Director
PGNY
Progyny, Inc. Healthcare
Director
CDNA
CareDx, Inc. Healthcare
KYTX
Kyverna Therapeutics, Inc.
URGN
UroGen Pharma Ltd. Healthcare
Director
FEC

Fred E Cohen

Cambridge, MA

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA